Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:AMS NASDAQ:BOLT NASDAQ:CME On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSAmerican Shared Hospital Services$2.48+2.1%$2.48$2.27▼$4.60$16.00M0.2944,643 shs374 shsBOLTBolt Biotherapeutics$5.81+2.8%$6.21$5.20▼$15.60$11.14M0.8911,852 shs23,775 shsCMECME Group$277.17+0.8%$276.31$193.25▼$290.79$99.88B0.442.38 million shs753,310 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSAmerican Shared Hospital Services+0.83%-2.41%+2.53%-10.33%-9.33%BOLTBolt Biotherapeutics-4.36%-5.63%-6.56%-14.16%-60.95%CMECME Group-0.74%-0.23%+2.04%+5.21%+39.59%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMSAmerican Shared Hospital ServicesN/AN/AN/AN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics3.0234 of 5 stars3.22.00.00.02.73.31.3CMECME Group4.4232 of 5 stars2.15.02.52.93.43.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMSAmerican Shared Hospital Services 0.00N/AN/AN/ABOLTBolt Biotherapeutics 2.33Hold$50.00760.59% UpsideCMECME Group 2.13Hold$261.80-5.55% DownsideCurrent Analyst Ratings BreakdownLatest BOLT, AMS, and CME Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/15/2025CMECME GroupPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$283.00 ➝ $296.007/10/2025CMECME GroupBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$283.00 ➝ $299.007/3/2025CMECME GroupCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$265.00 ➝ $275.006/4/2025CMECME GroupOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$282.00 ➝ $300.005/24/2025CMECME GroupErste Group BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold5/20/2025BOLTBolt BiotherapeuticsLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$80.005/13/2025BOLTBolt BiotherapeuticsStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$25.00 ➝ $20.004/25/2025CMECME GroupUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$290.00 ➝ $305.004/24/2025CMECME GroupMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$301.00 ➝ $304.004/24/2025CMECME GroupKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetMarket Perform ➝ Market Perform$265.00 ➝ $273.004/24/2025CMECME GroupJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$223.00 ➝ $211.00(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMSAmerican Shared Hospital Services$28.34M0.56$0.91 per share2.72$4.68 per share0.53BOLTBolt Biotherapeutics$3.64M3.06N/AN/A$29.89 per share0.19CMECME Group$6.13B16.29$11.34 per share24.44$73.66 per share3.76Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMSAmerican Shared Hospital Services$2.19M$0.6011.278.27N/A5.00%-4.20%-2.09%8/13/2025 (Estimated)BOLTBolt Biotherapeutics-$63.12M-$33.40N/AN/AN/AN/A-94.51%-59.07%8/12/2025 (Estimated)CMECME Group$3.53B$9.9427.8825.224.8357.71%14.03%2.76%7/23/2025 (Estimated)Latest BOLT, AMS, and CME EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025AMSAmerican Shared Hospital Services-$0.07N/AN/AN/A$7.29 millionN/A8/12/2025Q2 2025BOLTBolt Biotherapeutics-$6.40N/AN/AN/A$0.82 millionN/A7/23/2025Q2 2025CMECME Group$2.98N/AN/AN/A$1.68 billionN/A5/12/2025Q1 2025BOLTBolt Biotherapeutics-$6.80-$5.80+$1.00-$0.29$0.77 million$1.22 million4/23/2025Q1 2025CMECME Group$2.61$2.80+$0.19$2.62$1.56 billion$1.64 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMSAmerican Shared Hospital ServicesN/AN/AN/AN/AN/ABOLTBolt Biotherapeutics$0.366.20%N/AN/A N/ACMECME Group$5.001.80%N/A50.30%N/ALatest BOLT, AMS, and CME DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CMECME Groupquarterly$1.251.76%6/9/20256/9/20256/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMSAmerican Shared Hospital Services0.581.871.87BOLTBolt Biotherapeutics0.483.133.13CMECME Group0.131.021.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMSAmerican Shared Hospital Services23.16%BOLTBolt Biotherapeutics86.70%CMECME Group87.75%Insider OwnershipCompanyInsider OwnershipAMSAmerican Shared Hospital Services23.80%BOLTBolt Biotherapeutics30.90%CMECME Group0.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMSAmerican Shared Hospital Services106.45 million4.92 millionNot OptionableBOLTBolt Biotherapeutics901.92 million1.33 millionNot OptionableCMECME Group3,760360.36 million359.28 millionOptionableBOLT, AMS, and CME HeadlinesRecent News About These CompaniesCME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth2 hours ago | zacks.comCME Group Inc. (NASDAQ:CME) Shares Purchased by Cullen Frost Bankers Inc.5 hours ago | marketbeat.comCME Group Inc. (NASDAQ:CME) Shares Acquired by Parcion Private Wealth LLC5 hours ago | marketbeat.comBridgewater Advisors Inc. Acquires Shares of 2,394 CME Group Inc. (NASDAQ:CME)July 16 at 7:32 AM | marketbeat.comKraken Derivatives US Launches in Multiple States, Expanding Access to Crypto FuturesJuly 16 at 7:31 AM | news.bitcoin.comWealthfront Advisers LLC Purchases 6,418 Shares of CME Group Inc. (NASDAQ:CME)July 16 at 6:43 AM | marketbeat.comDakota Wealth Management Purchases 3,359 Shares of CME Group Inc. (NASDAQ:CME)July 16 at 6:08 AM | marketbeat.comOVERSEA CHINESE BANKING Corp Ltd Acquires Shares of 2,708 CME Group Inc. (NASDAQ:CME)July 16 at 6:01 AM | marketbeat.comKraken launches Kraken Derivatives US, bringing CME crypto futures to regulated trading in five statesJuly 16 at 4:40 AM | cryptobriefing.comCCME Group (CME) Projected to Post Quarterly Earnings on WednesdayJuly 16 at 2:31 AM | marketbeat.comKraken Launches US-Regulated Derivatives Offering Powered by NinjaTraderJuly 15 at 1:19 PM | pymnts.comCME Group (NASDAQ:CME) Given New $296.00 Price Target at Piper SandlerJuly 15 at 11:19 AM | marketbeat.comBryn Mawr Capital Management LLC Raises Stake in CME Group Inc. (NASDAQ:CME)July 15 at 9:32 AM | marketbeat.comCME Group Inc. (NASDAQ:CME) Shares Sold by Kornitzer Capital Management Inc. KSJuly 15 at 9:07 AM | marketbeat.comPatrick Mauro Investment Advisor INC. Has $13.35 Million Position in CME Group Inc. (NASDAQ:CME)July 15 at 7:58 AM | marketbeat.comSigma Planning Corp Buys 2,489 Shares of CME Group Inc. (NASDAQ:CME)July 15 at 6:03 AM | marketbeat.comCwm LLC Boosts Stake in CME Group Inc. (NASDAQ:CME)July 15 at 5:29 AM | marketbeat.comLexington church shooting: What we know about suspect, victims, motive and more - WLKYJuly 14 at 6:58 PM | news.google.comNMassachusetts Financial Services Co. MA Acquires 648,591 Shares of CME Group Inc. (NASDAQ:CME)July 14 at 9:12 AM | marketbeat.comBogart Wealth LLC Cuts Stock Position in CME Group Inc. (NASDAQ:CME)July 14 at 7:49 AM | marketbeat.comTurtle Creek Wealth Advisors LLC Acquires New Holdings in CME Group Inc. (NASDAQ:CME)July 14 at 6:50 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBig Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo LeadBy Gabriel Osorio-Mazilli | July 3, 2025View Big Bank Buybacks: Morgan Stanley, Citi, & Wells Fargo LeadBOLT, AMS, and CME Company DescriptionsAmerican Shared Hospital Services NYSEAMERICAN:AMS$2.48 +0.05 (+2.06%) As of 12:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.Bolt Biotherapeutics NASDAQ:BOLT$5.81 +0.16 (+2.83%) As of 12:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.CME Group NASDAQ:CME$277.17 +2.17 (+0.79%) As of 12:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Delta Air Lines Stock Rallies on New Guidance—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
